MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
1.714
-0.131
-7.09%
After Hours: 1.768 +0.053 +3.11% 18:47 05/13 EDT
OPEN
1.880
PREV CLOSE
1.845
HIGH
1.880
LOW
1.659
VOLUME
163.44K
TURNOVER
--
52 WEEK HIGH
2.550
52 WEEK LOW
1.030
MARKET CAP
12.86M
P/E (TTM)
-1.4821
1D
5D
1M
3M
1Y
5Y
1D
Uncovering Potential: BioRestorative Therapies's Earnings Preview
Benzinga · 11h ago
BioRestorative Therapies announces preliminary data from BRTX-100 trial in cLDD
TipRanks · 16h ago
BioRestorative Therapies Presents Preliminary Phase 2 BRTX-100 Data At ISCT 2025 Annual Meeting
Benzinga · 16h ago
PHASE 2 TRIAL OF BRTX-100 IN CLDD CONTINUES TO GENERATE POSITIVE PRELIMINARY BLINDED DATA
Reuters · 16h ago
Weekly Report: what happened at BRTX last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at BRTX last week (0428-0502)?
Weekly Report · 05/05 12:15
Weekly Report: what happened at BRTX last week (0421-0425)?
Weekly Report · 04/28 12:28
Weekly Report: what happened at BRTX last week (0414-0418)?
Weekly Report · 04/21 12:27
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.